Updated May 28, 2007 at 22:41 EST.
With news of Vectura’s new drug VR776 to treat premature ejaculation ( PE ), people who are affected by the condition are eager for information of how the medication would work. VR776 is a dry powder inhaler that has demonstrated quick efficiency – producing results in about 15 minutes after it is inhaled. A patient inhales, activating the aerosol medication. It is a slower inhaler than those currently available on the market, but it is has the potential to deliver more drug into the patient’s system.
Clinically, the drug has shown tremendous potential with no observable side effects. Dr. Chris Blackwell, CEO of Vectura, stated in a company press release, “
The initial evaluation of the results of this study endorses our belief that the potential remains for VR776 to be a rapidly-acting and effective treatment for PE patients. We are also very pleased that the study provides further validation of the effectiveness of our Aspirair dry powder inhaler device.”
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
